The document is an intimation for an earnings call to discuss the company's performance for the quarter and half year ended September 30, 2026 (Q2 & H1 FY2026-27).
The event is scheduled for Wednesday, October 28, 2026, at 08:30 AM IST.
The stated purpose of the event is to "discuss the performance for the quarter ended September 30, 2026."
The intimation is made pursuant to Regulation 30(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
Six management participants are listed:
Mr. Anand Roy, Managing Director and Chief Executive Officer
Mr. Amitabh Jain, Executive Director & Chief Operating Officer
Mr. Himanshu Walia, Executive Director & Chief Marketing Officer
Mr. Nilesh Kambli, Chief Financial Officer
Mr. Aneesh Srivastava, Chief Investment Officer
Mr. Sombit Bhattacharyya, Head - Investor Relations
Two methods of access are provided:
Option 1: A pre-registration link (https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=5650064&linkSecurityString=31b38271d0) to receive dial-in numbers and a PIN.
Option 2: Direct dial-in numbers with operator assistance, including universal access numbers for India (+91 22 6280 1341 / +91 22 7115 8242) and international toll-free numbers for the USA (18667462133), UK (08081011573), Hong Kong (800964448), and Singapore (8001012045).
The document does not indicate that a presentation, earnings deck, transcript, or recording will be made available, nor does it state that no unpublished price sensitive information (UPSI) will be shared.
No financial highlights, guidance references, or presentation summaries are included in the provided data.
Additional Notes Section
The document references an enclosure labeled "Annexure 1," which contains the detailed invite for the earnings call, including the management participant list and access details.
No financial data or figures were disclosed in this announcement.
The information is also being hosted on the company's website at https://www.starhealth.in/.
